TY - JOUR
T1 - Pathways to care for people with dementia
T2 - An international multicentre study
AU - Volpe, Umberto
AU - Amin, Hania
AU - Ayinde, Olatunde O.
AU - Burns, Alistair
AU - Chan, Wai Chi
AU - David, Renaud
AU - Dejanovic, Slavica Djukic
AU - Djokic, Gorica
AU - Eraslan, Defne
AU - Fischer, Giulia A.L.
AU - Gracia-García, Patricia
AU - Hamdani, Syed Usman
AU - Han, Changsu
AU - Jafri, Hussain
AU - Kallivayalil, Roy A.
AU - Kriekaart, Roderick Leonard
AU - Kua, Ee Heok
AU - Lam, Linda C.W.
AU - Lecic-Tosevski, Dusica
AU - Leroi, Iracema
AU - Lobo, Antonio
AU - Mihai, Adriana
AU - Minhas, Fareed Aslam
AU - Mistry, Heena
AU - Ogundele, Afolakemi T.
AU - Olde Rikkert, Marcel G.M.
AU - Olivera, Javier
AU - Palumbo, Claudia
AU - Parker, Angela
AU - Pejuskovic, Bojana
AU - Riese, Florian
AU - Robert, Philippe
AU - Semrau, Maya
AU - Stoppe, Gabriela
AU - Sudhakar, Sanu
AU - Tirintica, Andreea Raluca
AU - Tofique, Sehrish
AU - Tsoi, Chris
AU - Wolski, Lucas
AU - Yalug, Irem
AU - Wang, Huali
AU - Yu, Xin
AU - Sartorius, Norman
N1 - Funding Information:
Authors wish to thank all patients who participated in the study, together with their families and caregivers, as well as all nurses and administrative personnel who contributed to data selection and management. Authors are also grateful to the members of the International Dementia Alliance–IDEAL Group and of the Association for the Improvement of Mental Health Programs (Switzerland) for their support, inspiration, and valuable suggestions. Dr Chan and Prof Lam acknowledge the valuable contribution of the Health and Medical Research Fund (Ref: SMH‐44) and the Mei Family Trust. Finally, Prof Han wishes to thank Professor Ki Woong Kim (Director of National Institute of Dementia, Seongnam, Korea).
Funding Information:
Authors wish to thank all patients who participated in the study, together with their families and caregivers, as well as all nurses and administrative personnel who contributed to data selection and management. Authors are also grateful to the members of the International Dementia Alliance?IDEAL Group and of the Association for the Improvement of Mental Health Programs (Switzerland) for their support, inspiration, and valuable suggestions. Dr Chan and Prof Lam acknowledge the valuable contribution of the Health and Medical Research Fund (Ref: SMH-44) and the Mei Family Trust. Finally, Prof Han wishes to thank Professor Ki Woong Kim (Director of National Institute of Dementia, Seongnam, Korea).
Publisher Copyright:
© 2019 John Wiley & Sons, Ltd.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Objective: The aim of the present study was to characterize the clinical pathways that people with dementia (PwD) in different countries follow to reach specialized dementia care. Methods: We recruited 548 consecutive clinical attendees with a standardized diagnosis of dementia, in 19 specialized public centres for dementia care in 15 countries. The WHO “encounter form,” a standardized schedule that enables data concerning basic socio-demographic, clinical, and pathways data to be gathered, was completed for each participant. Results: The median time from the appearance of the first symptoms to the first contact with specialist dementia care was 56 weeks. The primary point of access to care was the general practitioners (55.8%). Psychiatrists, geriatricians, and neurologists represented the most important second point of access. In about a third of cases, PwD were prescribed psychotropic drugs (mostly antidepressants and tranquillizers). Psychosocial interventions (such as psychological counselling, psychotherapy, and practical advice) were delivered in less than 3% of situations. The analyses of the “pathways diagram” revealed that the path of PwD to receiving care is complex and diverse across countries and that there are important barriers to clinical care. Conclusions: The study of pathways followed by PwD to reach specialized care has implications for the subsequent course and the outcome of dementia. Insights into local differences in the clinical presentations and the implementation of currently available dementia care are essential to develop more tailored strategies for these patients, locally, nationally, and internationally.
AB - Objective: The aim of the present study was to characterize the clinical pathways that people with dementia (PwD) in different countries follow to reach specialized dementia care. Methods: We recruited 548 consecutive clinical attendees with a standardized diagnosis of dementia, in 19 specialized public centres for dementia care in 15 countries. The WHO “encounter form,” a standardized schedule that enables data concerning basic socio-demographic, clinical, and pathways data to be gathered, was completed for each participant. Results: The median time from the appearance of the first symptoms to the first contact with specialist dementia care was 56 weeks. The primary point of access to care was the general practitioners (55.8%). Psychiatrists, geriatricians, and neurologists represented the most important second point of access. In about a third of cases, PwD were prescribed psychotropic drugs (mostly antidepressants and tranquillizers). Psychosocial interventions (such as psychological counselling, psychotherapy, and practical advice) were delivered in less than 3% of situations. The analyses of the “pathways diagram” revealed that the path of PwD to receiving care is complex and diverse across countries and that there are important barriers to clinical care. Conclusions: The study of pathways followed by PwD to reach specialized care has implications for the subsequent course and the outcome of dementia. Insights into local differences in the clinical presentations and the implementation of currently available dementia care are essential to develop more tailored strategies for these patients, locally, nationally, and internationally.
KW - dementia
KW - geriatric psychiatry
KW - health care policy
KW - outcome
KW - pathways to care
KW - time to diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85076146950&partnerID=8YFLogxK
U2 - 10.1002/gps.5223
DO - 10.1002/gps.5223
M3 - Article
C2 - 31657091
AN - SCOPUS:85076146950
SN - 0885-6230
VL - 35
SP - 163
EP - 173
JO - International Journal of Geriatric Psychiatry
JF - International Journal of Geriatric Psychiatry
IS - 2
ER -